Pharmaceutical

Amneal files again for FDA approval of first dihydroergotamine autoinjector

Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe autoinjector to treat tough-to-treat headaches.

Nov 23, 2024 - 06:00
Amneal files again for FDA approval of first dihydroergotamine autoinjector
Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe autoinjector to treat tough-to-treat headaches.
Read the original article

Tags:

Previous Article

Enveda raises $130m to advance AI-driven plant based drug development

Next Article

Zai Lab and Pfizer to commercialise XACDURO in China

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Achieve Life Sciences drug helps smokers quit in trial but would face stiff competition if approved

STAT+: Achieve Life Sciences drug helps smokers quit in...

May 23, 2023

STAT+: Will Medicare cover it? Drugs like Aduhelm are challenging its standard

STAT+: Will Medicare cover it? Drugs like Aduhelm are c...

May 29, 2023

Zuckerberg and Chan announce a New York biohub to build disease-fighting cellular machines

Zuckerberg and Chan announce a New York biohub to build...

Oct 18, 2023